BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33493928)

  • 1. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B; Luo J; Guo S; Wang L
    Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice.
    Jiang B; Guo S; Shi D; Guo C; Wang T
    Eur J Med Chem; 2013 Jun; 64():129-36. PubMed ID: 23644196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
    Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
    Li M; Li H; Min X; Sun J; Liang B; Xu L; Li J; Wang SH; Xu X
    J Med Chem; 2024 May; 67(10):8406-8419. PubMed ID: 38723203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides.
    Luo J; Zheng M; Jiang B; Li C; Guo S; Wang L; Li X; Yu R; Shi D
    Br J Pharmacol; 2020 Oct; 177(19):4464-4480. PubMed ID: 32663313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B.
    Li XQ; Xu Q; Luo J; Wang LJ; Jiang B; Zhang RS; Shi DY
    Eur J Med Chem; 2017 Aug; 136():348-359. PubMed ID: 28511130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly Selective Protein Tyrosine Phosphatase Inhibitor, 2,2',3,3'-Tetrabromo-4,4',5,5'-tetrahydroxydiphenylmethane, Ameliorates Type 2 Diabetes Mellitus in BKS db Mice.
    Li C; Luo J; Guo S; Jia X; Guo C; Li X; Xu Q; Shi D
    Mol Pharm; 2019 May; 16(5):1839-1850. PubMed ID: 30974944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
    Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
    ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
    Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
    Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 2-ethoxy-4-(methoxymethyl)benzamide derivatives as potent and selective PTP1B inhibitors.
    Xie F; Liang Y; Xia Y; Luo S; Jiang F; Fu L
    Bioorg Chem; 2019 Nov; 92():103273. PubMed ID: 31539748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors.
    Maheshwari N; Karthikeyan C; Bhadada SV; Verma AK; Sahi C; Moorthy NSHN; Trivedi P
    Bioorg Chem; 2019 Nov; 92():103221. PubMed ID: 31499261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
    Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
    Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.
    Luo J; Xu Q; Jiang B; Zhang R; Jia X; Li X; Wang L; Guo C; Wu N; Shi D
    Br J Pharmacol; 2018 Jan; 175(1):140-153. PubMed ID: 29059712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of potent and selective inhibitors targeting protein tyrosine phosphatase 1B (PTP1B).
    Jin J; Ye X; Boateng D; Dai K; Ye F; Du P; Yu H
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2358-2363. PubMed ID: 31221555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.